Chrysophanol treatment may be a strategy to overcome the oncogenic functions of KITENIN, which is expressed in many types of cancer, and is associated with poor prognosis, metastasis, tumorigenesis, and aerobic glycolysis. This evidence concerns the gene VANGL1 and cancer.